Cefarka S 250mg/125mg Injection
Marketer
Mediarka Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cefarka S 250mg/125mg Injection
Cefarka S 250mg/125mg Injection, a dual-action antibiotic, combats bacterial infections by inhibiting microbial growth and propagation. Administered only by a healthcare provider, this medication requires adherence to the prescribed schedule. Complete the full course of treatment, even with symptom improvement, as premature cessation may compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; contact your doctor if these worsen. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, refrain from driving if drowsiness or dizziness occurs. Prioritize rest, proper nutrition, and hydration for optimal recovery. Your doctor may order tests to monitor the medication's impact.
Primary Ingredients of Cefarka S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Cefarka S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cefarka S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefarka S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefarka S 250mg/125mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
How Cefarka S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefarka S 250mg/125mg Injection, offer a dual antibiotic approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by countering bacterial resistance mechanisms, thereby improving its effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Cefarka S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefarka S (250mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; however, data from human trials are scarce.
Breast feedingCAUTION
Administering Cefarka S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Cefarka S (250mg/125mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefarka S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Cefarka S 250mg/125mg, requires careful administration for individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the Cefarka S 250mg/125mg injection dosage is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cefarka S 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Cefarka S 250mg/125mg Injection, seek immediate medical advice.
Facts to Know About Cefarka S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently